Literature DB >> 23640203

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.

Hiroshi Hayami1, Satoshi Takahashi, Kiyohito Ishikawa, Mitsuru Yasuda, Shingo Yamamoto, Shinya Uehara, Ryoichi Hamasuna, Tetsuro Matsumoto, Shinichi Minamitani, Akira Watanabe, Aikichi Iwamoto, Kyoichi Totsuka, Junichi Kadota, Keisuke Sunakawa, Junko Sato, Hideaki Hanaki, Taiji Tsukamoto, Hiroshi Kiyota, Shin Egawa, Kazushi Tanaka, Soichi Arakawa, Masato Fujisawa, Hiromi Kumon, Kanao Kobayashi, Akio Matsubara, Seiji Naito, Katsunori Tatsugami, Takamasa Yamaguchi, Shin Ito, Mototsugu Kanokogi, Harunori Narita, Hiromi Kawano, Takahide Hosobe, Kazuo Takayama, Toru Sumii, Akira Fujii, Takashi Sato, Takamine Yamauchi, Masanobu Izumitani, Hirofumi Chokyu, Hideari Ihara, Kikuo Akiyama, Masaru Yoshioka, Satoshi Uno, Koichi Monden, Motonori Kano, Shinichi Kaji, Shuichi Kawai, Kenji Ito, Hisato Inatomi, Hirofumi Nishimura, Toshihiro Ikuyama, Shohei Nishi, Koichi Takahashi, Yukihiro Kawano, Satoshi Ishihara, Kengo Tsuneyoshi, Shinji Matsushita, Takashi Yamane, Takaoki Hirose, Shigeru Fujihiro, Katsuhisa Endo, Yasuhiko Oka, Koh Takeyama, Takahiro Kimura, Tetsuji Uemura.   

Abstract

The Japanese surveillance committee conducted the first nationwide surveillance of antimicrobial susceptibility patterns of uropathogens responsible for female acute uncomplicated cystitis at 43 hospitals throughout Japan from April 2009 to November 2010. In this study, the causative bacteria (Escherichia coli and Staphylococcus saprophyticus) and their susceptibility to various antimicrobial agents were investigated by isolation and culturing of bacteria from urine samples. In total, 387 strains were isolated from 461 patients, including E. coli (n = 301, 77.8 %), S. saprophyticus (n = 20, 5.2 %), Klebsiella pneumoniae (n = 13, 3.4 %), and Enterococcus faecalis (n = 11, 2.8 %). S. saprophyticus was significantly more common in premenopausal women (P = 0.00095). The minimum inhibitory concentrations of 19 antibacterial agents used for these strains were determined according to the Clinical and Laboratory Standards Institute manual. At least 87 % of E. coli isolates showed susceptibility to fluoroquinolones and cephalosporins, and 100 % of S. saprophyticus isolates showed susceptibility to fluoroquinolones and aminoglycosides. The proportions of fluoroquinolone-resistant E. coli strains and extended-spectrum β-lactamase (ESBL)-producing E. coli strains were 13.3 % and 4.7 %, respectively. It is important to confirm the susceptibility of causative bacteria for optimal antimicrobial therapy, and empiric antimicrobial agents should be selected by considering patient characteristics and other factors. However, the number of isolates of fluoroquinolone-resistant or ESBL-producing strains in gram-negative bacilli may be increasing in patients with urinary tract infections (UTIs) in Japan. Therefore, these data present important information for the proper treatment of UTIs and will serve as a useful reference for future surveillance studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640203     DOI: 10.1007/s10156-013-0606-9

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  14 in total

1.  Molecular epidemiological characterization of uropathogenic escherichia coli from an outpatient urology clinic in rural Japan.

Authors:  Yasuyo D Umene; Lisa K Wong; Tomoya Satoh; Kunikazu Yamane; Mari Matsui; Lee W Riley; Yoshichika Arakawa; Satowa Suzuki
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

2.  Fur Represses Adhesion to, Invasion of, and Intracellular Bacterial Community Formation within Bladder Epithelial Cells and Motility in Uropathogenic Escherichia coli.

Authors:  Kumiko Kurabayashi; Tomohiro Agata; Hirofumi Asano; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

3.  Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.

Authors:  Mehreen Arshad; Carlos C Goller; Danielle Pilla; Frank J Schoenen; Patrick C Seed
Journal:  J Infect Dis       Date:  2015-12-15       Impact factor: 5.226

4.  Staphylococcus saprophyticus Bacteremia originating from Urinary Tract Infections: A Case Report and Literature Review.

Authors:  Jaehyung Hur; Anna Lee; Jeongmin Hong; Won-Yong Jo; Oh-Hyun Cho; Sunjoo Kim; In-Gyu Bae
Journal:  Infect Chemother       Date:  2016-06-30

Review 5.  Prevalence of antibiotic susceptibility and resistance of Escherichia coli in acute uncomplicated cystitis in Korea: Systematic review and meta-analysis.

Authors:  Jae Heon Kim; Hwa Yeon Sun; Tae Hyong Kim; Sung Ryul Shim; Seung Whan Doo; Won Jae Yang; Eun Jung Lee; Yun Seob Song
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

6.  Staphylococcus haemolyticus epididymo-orchitis and bacteraemia: a case report.

Authors:  Christina Pindar; Roberto A Viau
Journal:  JMM Case Rep       Date:  2018-07-05

Review 7.  Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance.

Authors:  Dong Sup Lee; Seung-Ju Lee; Hyun-Sop Choe
Journal:  Biomed Res Int       Date:  2018-09-26       Impact factor: 3.411

Review 8.  Coagulase-Negative Staphylococci Pathogenomics.

Authors:  Xavier Argemi; Yves Hansmann; Kevin Prola; Gilles Prévost
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

9.  Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community.

Authors:  M Matsukawa; M Igarashi; H Watanabe; L Qin; M Ohnishi; J Terajima; S Iyoda; T Morita-Ishihara; K Tateda; Y Ishii; T Saga; K Aoki; R A Bonomo
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 10.  Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis.

Authors:  George G Zhanel; Andrew J Walkty; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-10       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.